Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
Reviva Pharmaceuticals – Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension...
Reviva Pharmaceuticals – Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension...
SANTA CLARA, Calif., March 24, 2025--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today...
Hudson's Bay Company is nearly a billion dollars in debt, according to court filings that paint a dire portrait of...
SIU’s winning Chartered Financial Analyst (CFA) team (left to right): Nick Dean, Reagan Basso, Tim Marlo (clinical associate professor and...
Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and development of innovative...
Black entrepreneurs in Montreal say systemic financial barriers continue to halt success rates of Black-owned businesses. A Montreal-based business that...